Filter
46
Filtered Results: 46
Text search:
гепатит
Featured
Recommendations
8
New Publications
16
Language
Document type
No document type
19
Guidelines
17
Fact sheets
3
Manuals
2
Strategic & Response Plan
2
Studies & Reports
1
Resource Platforms
1
Videos
1
Countries / Regions
Russia
4
Ukraine
2
Armenia
2
Global
2
Eastern Europe
2
Tajikistan
1
Albania
1
Africa
1
Latin America and the Carribbean
1
South–East Asia Region
1
Argentina
1
South Africa
1
Moldova
1
Authors & Publishers
Publication Years
Category
Hepatitis
42
Pediatrics
8
Gynaecology & Obstetrics
3
Paediatrics
2
Virology
2
Guidelines
2
HIV & STI
2
Communicable Diseases
1
Countries
1
Policies
1
Communicable Diseases
1
Maternal Health
1
TB
1
Toolboxes
Hepatitis
9
Paediatrics
3
Opportunistic Infections
2
Women
2
Prevention of mother-to-child transmission (PMTCT)
2
Eastern Europe & Central Asia
2
Drugs
1
TB & Drug Abuse
1
Adults
1
Ukraine
1
Prevention Guidelines
1
Policies
1
Transgender People
1
Men who have sex with men (MSM)
1
People who injecting Drugs
1
IEC Materials
1
HIV / AIDS
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Information, Resources & Websites
1
Armenia
1
Drug resistant TB
1
Co-Morbidities (except TB)
1
Substance Use Disorders & Addiction
1
HIV / AIDS
1
Clinical Guidelines
1
HIV in Key Populations
1
Prisoners
1
Technical report
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology...
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst...
WHO’s Dr Philippa Easterbrook gives a situation update on the recent hepatitis outbreak affecting children including possible causes and steps parents, caregivers and countries should take.
